Clinical Trial Update: A Phase 1b Study of QX1206 in T2DM Patients With NAFLD [Phase 1]

View source ↗

Summary

Phase 1b trial update describing the ongoing study of QX1206 in patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• QX1206

Snippet

Sponsor: 1Globe Health Institute | Conditions: Type 2 Diabetes Mellitus (T2DM), Non-Alcoholic Fatty Liver Disease (NAFLD) | Phase 1 | Status: RECRUITING